Was ist die Webseite?

SHL Medical

Startseite
Schweiz
Zug
SHL Medical

SHL Medical is a world-leading designer, developer, and manufacturer of autoinjectors, pen injectors, and advanced wearable drug delivery systems.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients’ independence.

08/10/2025

We’re delighted to share that SHL Medical is featured in the debut dual-chamber systems edition of ONdrugDelivery magazine, where our Senior Customer Solutions Manager Dr. Nina Fetz introduces Reunite™, our novel dual-chamber autoinjector designed for the automated reconstitution and delivery of lyophilized formulations.

Already a finalist for the 2025 CPHI Pharma Award, Reunite continues to gain industry recognition - now also named a finalist for the 2025 PDA Drug Delivery Innovation Award. These developments highlight our dedication to advancing self-injection technologies by addressing the challenges of complex biologics and making these therapies more accessible to patients – enabling the delivery of lyophilized drugs with the same ease as a standard autoinjector.

Read on how we’re advancing dual-chamber autoinjector technology with Reunite to address the complexities of biologics and support pharma partners in unlocking new therapies 👉 https://bit.ly/4h1zl27

07/10/2025

Large-volume subcutaneous (LVSC) delivery brings both opportunity and complexity, and cartridge-based autoinjectors are at the center of that shift.

In our latest blog, SHL Medical’s Vince Masciopinto shares insights from Endpoints’ Manufacturing Day’s webinar on why strong partnerships with CDMOs are essential for building the ecosystem for large-volume therapies, and how the Maggie® 5.0 autoinjector exemplifies this proactive approach.

Read the blog 👉 https://bit.ly/432mk2d

06/10/2025

What does it take to design an intuitive user interface for large-volume subcutaneous infusion devices?

At the 2025 PDA Universe, Matchstick LLC’s Madeleine Anderson and Katie Brigham, as well as SHL Medical’s Nenad Suknovic, PhD will co-present findings from a mixed-methods study on patients self-administrating formulations with large-volume subcutaneous infusion devices.

Join the session and be part of the discussion on designing interfaces that put patient usability first.

04/10/2025

SHL Medical joins KiSS Science 2025 for the first time!

Now in its seventh year, this nationwide initiative is organized by Taiwan’s National Science and Technology Council and opens the doors of research institutes and companies to high school students.

On December 5, 11, and 12, we will welcome students to our Taiwan-Liufu facility for a guided site tour and an insightful lecture on how science, engineering, and design come together in the development of autoinjectors. Students will discover how an idea moves from device concept, through prototyping, to large-scale manufacturing that ultimately supports patients worldwide.

Our involvement in KiSS Science builds on SHL Medical’s global programs to engage and develop STEM talent, reflecting our commitment to nurturing the next generation. From internships and apprenticeships to STEM outreach initiatives worldwide, we’re dedicated to inspiring future innovators and creating opportunities for young talents to grow with us.

If you’re inspired by science, engineering, and design, and want to be part of shaping the future of drug delivery, we’d love to have you join our journey.

Explore career opportunities at SHL Medical 👉 https://bit.ly/3Cy1ttV

03/10/2025

SHL Medical will debut at ObesityWeek® 2025 in Atlanta from November 4–6, joining researchers, clinicians, and pharma companies to explore collaborative solutions to the global challenge of obesity.

According to WHO, more than a billion people worldwide are living with obesity today. Closely linked to conditions such as cardiovascular diseases and type 2 diabetes, obesity has become a critical public health priority. Among the treatment options, self-injected GLP-1 receptor agonists (GLP-1 RAs) have emerged as a key therapy for improving outcomes.

At SHL Medical, we support these therapies through our advanced self-injection solutions. We’re excited to attend for the first time to showcase our device portfolio, including our flagship Molly® modular platform autoinjectors, our newly launched dual-chamber cartridge-based Reunite™ autoinjector for lyophilized drugs, our large-volume, cartridge-based Maggie®, and our versatile electromechanical Elexy™.

We look forward to engaging with obesity experts on how we can work together to improve patient outcomes in the cardiometabolic space.

📍 Visit us at Tabletop #916 to learn how we can support your molecule for obesity treatment.

🔗 Read more: https://www.shl-medical.com/news-insights/events/shl-medical-showcases-drug-delivery-solutions-obesityweek-2025

02/10/2025

We’re excited to be co-presenting with Matchstick, LLC at PDA Universe!

In this poster presentation, we’ll be sharing findings from a joint study, led by Matchstick, on patient preferences in large-volume subcutaneous drug delivery systems.

Join Matchstick’s Katie Brigham and Chris Franzese, PharmD, as well as SHL Medical’s Dr. Nina Fetz as they walk through insights on the device attributes that matter most to patients.

Partnerships like this with Matchstick show how patient insights can advance patient-centric LVSC delivery. See the full program of SHL Medical talks at Parenteral Drug Association - PDA Universe of Pre-Filled Syringes and Injection Devices 2025 ⬇️

https://bit.ly/4nbypKm

01/10/2025

When Typhoon Ragasa struck eastern Taiwan, it left behind not only destruction but also families and children facing an uncertain road to recovery. At SHL Medical, we’re committed to supporting communities in times of crisis.

SHL Medical has donated NT$300,000 to 台灣世界展望會 World Vision Taiwan to provide sustained relief for affected families. The funds will support household repair subsidies, replacement of essential furniture and appliances, school supplies, emergency living support, as well as community cleanup and restoration.

Alongside this, our colleagues across Taiwan have stepped forward to make additional donations and dedicate personal time to support relief activities in Hualien. Their willingness to act reflects not only compassion for those affected, but also the strength of SHL Medical’s culture: one where solidarity and care extend beyond the workplace.

Together, these efforts highlight our collective commitment to the communities we serve, not only in moments of crisis but throughout the journey of recovery. 💙

30/09/2025

Reunite™ is a finalist for the 2025 CPHI Pharma Award in the Drug Delivery and Device Innovation category.

Just one week after launch, SHL Medical’s Reunite is receiving industry recognition for advancing drug delivery and device innovation. Developed as an easy-to-use, dual-chamber cartridge autoinjector, Reunite supports the automated reconstitution and delivery of lyophilized drugs with just three simple steps: unlock, twist, push.

This nomination highlights how SHL Medical combines technical rigor with usability, making lyophilized drug delivery as straightforward as a using a standard autoinjector.

We’re proud to see Reunite spotlighted so early in its journey, and even more excited to discuss its features with industry peers at Parenteral Drug Association - PDA Universe in Vienna, CPHI Frankfurt, and PODD® in Boston!

Learn more about Reunite ➡️ https://bit.ly/3KiswNa

29/09/2025

💙 What makes a company a great place to work?

SHL Medical’s Senior Director of Human Resources Penny Liao joined other nominees of the Taoyuan Golden Award for Best Employer on a podcast with CommonWealth Magazine to share how we foster workplace wellbeing. The discussion centered on what it means to be a good employer--listening to employees, addressing their real needs, and creating an environment where they can thrive.

At SHL Medical, we believe care for people is inseparable from our mission. Just as our products support patients in enhancing their everyday lives, we are equally dedicated to supporting the people who make this possible. From flexible work arrangements to family-friendly policies, our commitment is built on respect, trust, and mutual growth.

✨ Interested in building a career at SHL Medical? Explore opportunities here: https://www.shl-medical.com/careers

27/09/2025

🚀 Milestone Alert: 400 strong in North Charleston!

In just six months since our grand opening, SHL Medical’s North Charleston site has grown to a team of 400 employees, and we’re still hiring. 🙌

From our first job fair to building state-of-the-art production lines, this milestone reflects more than numbers: it’s about people. Every engineer, operator, and support team member is helping us build a hub of innovation and opportunity in South Carolina, advancing our mission to enable patients’ independence worldwide. 🌍

We’re proud of how far we’ve come and excited for what’s ahead.

👉 Want to be part of our journey? Explore open roles here: https://bit.ly/3Cy1ttV

26/09/2025

Biologics and protein-based drugs are often unstable in liquid form, and lyophilization is a critical method of preservation. But while stability improves, reconstitution and delivery introduce new challenges for pharma and device developers.

At PDA Universe 2025, SHL Medical’s Seda Aksel, PhD and Lyophilization Technology Inc.’s Michael Thomas, MScPharm will share insights on how innovative drug delivery systems can simplify reconstitution and enable more reliable delivery of lyophilized formulations.

The session will also spotlight the technological features of our dual-chamber cartridge autoinjector, Reunite™, and the successful partnership with our partner in advancing solutions for lyophilized therapies.

Join us at PDA Universe to explore new approaches for drug-device innovation through science and collaboration.

📌 Full session at Parenteral Drug Association - PDA Universe 2025: https://bit.ly/4nbypKm

25/09/2025

Reunite™ builds on nearly a decade of experience with SHL Medical’s Needle Isolation Technology (NIT®), a pre-attached needle system developed for cartridge-based autoinjectors.

With NIT, the needle remains hidden inside a closed system until use, eliminating manual needle handling. NIT also provides complete control over cannula gauge and length to support target injection time and depth, independent of the primary container.

From metabolic therapies in 2017 to dermatological treatments in 2024, the market-proven NIT is now advancing lyophilized drug delivery through Reunite.

Learn more about NIT and Reunite 👉 https://bit.ly/3KiswNa

Adresse

Zug

Webseite

http://www.shl-medical.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von SHL Medical erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an SHL Medical senden:

Verknüpfungen

Wollen Sie Ihr Praxis zum Top-Klinik in Zug machen?

Our Story

SHL Medical is a world-leading provider of drug delivery solutions. We design, develop, and manufacture advanced drug delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We also offer design-to-build and contract manufacturing services for products such as laboratory handling equipment, neurosurgical devices, and industrial equipment.

By integrating our experienced development teams with efficient manufacturing and a skilled workforce, we have developed a successful business model that allows us to provide comprehensive solutions for demanding requirements of the industry. As the largest company in SHL Group, SHL Medical continues to offer experience, excellence, and vision to customers and partners all over the world.